Results 61 to 70 of about 690 (122)

Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A. [PDF]

open access: yesEur J Transl Myol, 2023
Mastrapasqua M   +13 more
europepmc   +1 more source

Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. [PDF]

open access: yesBiomolecules, 2023
Rawls A   +5 more
europepmc   +1 more source

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy

open access: yesThe Application of Clinical Genetics, 2019
Quynh Nguyen,*,1 Kenji Rowel Q Lim,*,1 Toshifumi Yokota,1,21Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; 2The Friends of Garrett Cumming Research & Muscular Dystrophy Canada,
Nguyen Q, Lim KRQ, Yokota T
doaj  

Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy. [PDF]

open access: yesHum Mol Genet, 2022
Smith SJ   +6 more
europepmc   +1 more source

Clinico-genetic heterogeneity in Pakistani families affected with muscular dystrophies. [PDF]

open access: yesMol Biol Rep
Ahmad R   +5 more
europepmc   +1 more source

LAMA2 Triple Variant in a Mexican Child with Congenital Muscular Dystrophy. [PDF]

open access: yesAnn Indian Acad Neurol
Pinto-Escalante D   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy